IP Library Granted Patent US 9,663,774
Granted Patent B2
US 9,663,774 · App. 14/725,470 · Granted May 30, 2017

Polypeptides having endoglucanase activity and polynucleotides encoding same

Inventors: Nikolaj Spodsberg (Bagsvaerd, DK); Tarana Shagasi (Davis, CA)
Assignee: NOVOZYMES, INC.
C12N9/2437C12Y302/01004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,663,774
App. No.
14/725,470
Granted
May 30, 2017
Kind
B2
Abstract

The present invention relates to isolated polypeptides having endoglucanase activity, catalytic domains, cellulose binding domains and polynucleotides encoding the polypeptides, catalytic domains or cellulose binding domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains or cellulose binding domains.

Claims (19)

1. An isolated polypeptide comprising a catalytic domain, wherein said catalytic domain is selected from the group consisting of:

(a) a catalytic domain having at least 95% sequence identity to amino acids 19 to 397 of SEQ ID NO: 2;

(b) a catalytic domain encoded by a polynucleotide having at least 95% sequence identity to the catalytic domain of SEQ ID NO: 1;

(c) a variant of amino acids 19 to 397 of SEQ ID NO: 2 comprising a substitution, deletion, and/or insertion at one or several positions; and

(d) a fragment of the catalytic domain of (a), (b), or (c) that has endoglucanase activity;

wherein the catalytic domain is a variant comprising a substitution, deletion, or insertion of one or more amino acids of amino acids 19 to 397 of SEQ ID NO: 2.

2. The polypeptide of claim 1 , further comprising a cellulose binding domain.

3. The polypeptide of claim 1 , wherein the catalytic domain has at least 95% sequence identity to amino acids 19 to 397 of SEQ ID NO: 2.

4. A composition comprising the polypeptide of claim 1 .

5. An isolated polynucleotide encoding the polypeptide of claim 1 .

6. An isolated man-made variant polypeptide comprising a cellulose binding domain operably linked to a catalytic domain, wherein said binding domain is selected from:

(a) a cellulose binding domain having at least 95% sequence identity to amino acids 444 to 477 of SEQ ID NO: 2;

(b) a cellulose binding domain encoded by a polynucleotide having at least 95% sequence identity to nucleotides 1333 to 1431 of SEQ ID NO: 1;

(c) a variant of amino acids 444 to 477 of SEQ ID NO: 2 comprising a substitution, deletion, or insertion at one or several positions; or

(d) a fragment of (a), (b), (c) or (d) that has cellulose binding activity;

wherein the cellulose binding domain is a variant comprising a substitution, deletion, or insertion of one or more amino acids of amino acids 444 to 477 of SEQ ID NO: 2.

7. The polypeptide of claim 6 , wherein the cellulose binding domain has at least 95% sequence identity to amino acids 444 to 477 of SEQ ID NO: 2.

8. A composition comprising the polypeptide of claim 6 .

9. An isolated polynucleotide encoding the polypeptide of claim 6 .

Assignments (1)
CONFIRMATORY LICENSE Recorded Jul 22, 2019
From: NOVOZYMES, INC.
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 049825/0646 →
Priority Claims (1)
EP 11152252 · Jan 26, 2011 · regional
Continuity (3)
Continuation 13997715
Provisional Application 61576518 · Dec 16, 2011
Related Publication 20150259661A1 · Sep 17, 2015